Epidemiology, Diagnosis and Treatment of Myeloproliferative Neoplasms in Asian Countries

[APD-5] Epidemiology, diagnosis and treatment of myeloproliferative neoplasms in India

Rabindra Kumar Jena^1,2,3, Rabindra Kumar Jena¹ (1.SCB Medical College and Hospital, Cuttack, UTKAL UNIVERSITY Odisha, India, Clinical Hematology, India, 2.SCB Medical College and hospital, Cuttack, Utkal University, Odisha, India, 3.VSS Medical College and hospital, Burla, Sambalpur University, VIMSAR, Odisha, India)

NAME: Dr. RABINDRA KUMAR JENA
QUALIFICATION: M.D, Ph.D , FISHBT, VTP (U.S.A)
PRESENT POSITION: Prof & Head, Clinical Hematology, SCB Medical College, Odisha, IndiaSPECIAL TRAINING: i) Received training in BMT at University of Minnesota, USA being selected by American Society of Hematology ii)Received Advance Training on Thalassemia in Cyprus being Selected by Thalassemia International Federation
PROFESSIONAL: President, Indian Society of Hematology & Blood Transfusion POSITION Secretary of Eastern Hematology Group, Secretary, Odisha Hematology a) Member of the Editorial Board of Indian Journal of Hematology and International Hemoglobin Journal
b) Member of American Society of Hematology, European Hematology Association and much other Professional body of India
PUBLICATION:
: More than 100 publications in International and National Journals
SPECIAL INTEREST
: Blood and Marrow Transplant, Hematological Malignancy Hemoglobinopathy